George Anastassov
Director/Board Member at INCANNEX HEALTHCARE INC.
Net worth: 2 M $ as of 2024-06-29
Profile
George E.
Anastassov was the founder of AXIM Biotechnologies, Inc. (founded in 2014) where he served as Chairman from 2019 to 2020.
He was also the founder of CanChew Biotechnologies LLC (founded in 2012) where he was a Director from 2012 to 2013.
Additionally, he is the founder of Stichting Sanammad (founded in 2009) where he currently holds the position of Director & General Partner.
He is also the founder of Sanammad Pharmaceuticals BV (founded in 2014) where he currently holds the position of Director & General Partner.
Furthermore, he was the founder of APIRX Pharmaceuticals USA LLC (founded in 2017) where he served as Managing Director from 2017 to 2022.
Dr. Anastassov's current job(s) include being the President, Secretary, Treasurer & Director at CanChew License Co. and an Independent Non-Executive Director at Incannex Healthcare, Inc. (starting in 2023).
His former job includes being a Director at RYAH Group, Inc. from 2021 to 2022.
Dr. Anastassov's education history includes an undergraduate degree from the University of Tennessee and a doctorate degree from NYU College of Dentistry.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC.
4.85% | 2023-12-20 | 769,721 ( 4.85% ) | 2 M $ | 2024-06-29 |
George Anastassov active positions
| Companies | Position | Start |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Director/Board Member | 2023-10-31 |
| Stichting Sanammad | Founder | 2008-12-31 |
| Sanammad Pharmaceuticals BV | Founder | 2013-12-31 |
CanChew License Co.
 CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | President | - |
Former positions of George Anastassov
| Companies | Position | End |
|---|---|---|
| RYAH GROUP, INC. | Director/Board Member | 2022-12-05 |
APIRX Pharmaceuticals USA LLC
 APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Founder | 2021-12-31 |
| AXIM BIOTECHNOLOGIES, INC. | Chief Executive Officer | 2019-01-01 |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Founder | - |
Training of George Anastassov
| NYU College of Dentistry | Doctorate Degree |
| University of Tennessee | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| RYAH GROUP, INC. | Technology Services |
| INCANNEX HEALTHCARE INC. | Health Technology |
| Private companies | 5 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV | |
CanChew License Co.
CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | Commercial Services |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Stock Market
- Insiders
- George Anastassov
